Skip to content

E2F1-mediated transcriptional regulation of TMEM33 promotes colorectal cancer proliferation, metastasis, and EMT

Sep 2026 · Human Cell · Vol 39 · 0 citations · 40 references
Medicine

TL;DR

Silencing of TMEM33 markedly suppresses CRC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) both in vitro and in vivo, and significantly reduces subcutaneous tumor growth and pulmonary metastatic burden.

View source

Similar papers

Open access Sep 2026

DNA Polymerase θ Drives Colorectal Cancer Progression through Wnt/β-Catenin Activation and Shows Potential Association with Immunosuppressive Microenvironment Remodeling

The findings suggest that POLQ is a potential prognostic biomarker and therapeutic target, Though further validation in prospective, multicenter cohorts is warranted, andBioinformatic inference suggests a potential association with an immunosuppressive microenvironment, but this finding remains correlative and requires...

Li Li, Jian-Hua Wang, Fei-Long Zhou et al. · 0 citations
Open access Sep 2026

GAS5 Downregulation Promotes the Progression of Triple-Negative Breast Cancer by Regulating Tumor Cells-MDSCs Crosstalk

Simple Summary Triple-negative breast cancer (TNBC) is exceptionally aggressive. The long non-coding RNA growth arrest-specific 5 (GAS5) is associated with TNBC progression; however, the specific mechanism still requires further exploration. Herein, we observed a significant downregulation of GAS5 in TNBC cells and tis...

Jun-Ze Du, Xin He, Ling-Feng Tang et al. · 0 citations
Open access Sep 2026

Transcription factor KLF4 suppresses the malignant progression of colorectal cancer by activating ETFDH transcription.

Colorectal cancer (CRC) is a common cause of cancer-related deaths worldwide. Electron transfer flavoprotein dehydrogenase (ETFDH) is a novel prognostic biomarker for human CRC. However, the role and molecular mechanism of ETFDH in CRC are still unclear. DEGs in CRC development were identified using mRNA microarray dat...

Yan Zeng, Qiao-Zhen Liu, Ya-Li Xu et al. · 0 citations
Open access Sep 2026

Integrated multi-omics analyses reveal the role of PAXX in colorectal cancer progression and the tumor immune microenvironment

Functional and rescue experiments support MAPK/ERK signaling as a partial mediator of PAXX-associated malignant phenotypes and EMT-related alterations in CRC progression and its association with the tumor immune microenvironment.

Jin-Zhong Cao, Zi-Jing Wang, Xi Luo et al. · 0 citations
Open access Sep 2026

MXRA5 promotes the progression and metastasis of breast cancer via activation of the epithelial-to-mesenchymal transition pathway

Elevated MXRA5 expression exhibited a positive correlation with advanced lymph node metastasis and impaired clinical prognosis, and its potential as a valuable prognostic biomarker and therapeutic target for managing metastatic disease is revealed.

Jian Wang, Jie Tang, Yaoxin Wang · 0 citations
Open access Oct 2026

FOXM1-mediated transcriptional activation of CILP2 promotes malignant phenotypes and EMT-associated remodeling in clear cell renal cell carcinoma.

BACKGROUND Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of renal cancer and remains associated with aggressive progression and poor clinical outcomes. Cartilage intermediate layer protein 2 (CILP2), an extracellular matrix-associated secreted protein, has been implicated in tumor-rela...

Jia-Jia Sun, Tong-Zhen Yan, Zi-Yuan Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.